Stock Analysis

Unveiling High Insider Ownership Growth Stocks On Chinese Exchange July 2024

SHSE:688267
Source: Shutterstock

As of July 2024, Chinese equities have experienced fluctuations, with recent underwhelming manufacturing data highlighting concerns about the economy's momentum. This backdrop sets a critical stage for investors looking at growth companies with high insider ownership, as these entities often demonstrate a strong alignment between management’s interests and shareholder value, potentially offering stability in uncertain times.

Top 10 Growth Companies With High Insider Ownership In China

NameInsider OwnershipEarnings Growth
Zhejiang Jolly PharmaceuticalLTD (SZSE:300181)24%22.3%
Anhui Huaheng Biotechnology (SHSE:688639)31.5%28.4%
Cubic Sensor and InstrumentLtd (SHSE:688665)10.1%34.3%
KEBODA TECHNOLOGY (SHSE:603786)12.8%25.1%
Arctech Solar Holding (SHSE:688408)38.6%25.8%
Suzhou Sunmun Technology (SZSE:300522)36.5%63.4%
Sineng ElectricLtd (SZSE:300827)36.5%39.8%
Xi'an Sinofuse Electric (SZSE:301031)36.8%43.1%
Eoptolink Technology (SZSE:300502)26.7%38.8%
UTour Group (SZSE:002707)23%33.1%

Click here to see the full list of 367 stocks from our Fast Growing Chinese Companies With High Insider Ownership screener.

Let's take a closer look at a couple of our picks from the screened companies.

Goodwill E-Health Info (SHSE:688246)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Goodwill E-Health Info Co., Ltd. specializes in the research and development of medical information software in China, with a market capitalization of approximately CN¥2.74 billion.

Operations: The company primarily generates revenue from the development of medical information software in China.

Insider Ownership: 20.1%

Earnings Growth Forecast: 39.9% p.a.

Goodwill E-Health Info, despite its recent drop from the S&P Global BMI Index, shows promising growth prospects in China's healthcare sector. The company's earnings are expected to grow by 39.9% annually, outpacing both the industry and broader market forecasts significantly. Revenue growth is also strong at 22.4% per year. However, its return on equity is projected to remain low at 7.3%. These factors highlight a mixed yet optimistic outlook for Goodwill E-Health Info as a growth-oriented firm with substantial insider ownership.

SHSE:688246 Ownership Breakdown as at Jul 2024
SHSE:688246 Ownership Breakdown as at Jul 2024

China Catalyst Holding (SHSE:688267)

Simply Wall St Growth Rating: ★★★★★☆

Overview: China Catalyst Holding Co., Ltd. operates in the research, development, production, and sale of zeolite catalysts, customized process package solutions, and fine chemicals both domestically and internationally, with a market capitalization of approximately CN¥3.38 billion.

Operations: The company generates revenue primarily through its chemical reagent and auxiliary manufacturing segment, which accounted for CN¥625.39 million.

Insider Ownership: 31.7%

Earnings Growth Forecast: 23% p.a.

China Catalyst Holding has demonstrated robust growth with a significant increase in quarterly revenue and net income, rising from CNY 123.41 million to CNY 198.92 million and CNY 2.05 million to CNY 35.07 million respectively. Earnings per share also saw substantial growth from CNY 0.01 to CNY 0.2. Despite these gains, its forecasted return on equity remains low at 6.1%. Additionally, the company's dividend coverage by cash flows appears weak, suggesting potential sustainability issues for payouts.

SHSE:688267 Earnings and Revenue Growth as at Jul 2024
SHSE:688267 Earnings and Revenue Growth as at Jul 2024

MCLON JEWELLERYLtd (SZSE:300945)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: MCLON JEWELLERY Co., Ltd. operates as a jewelry retailer in China and internationally, with a market capitalization of approximately CN¥2.29 billion.

Operations: The company generates revenue through jewelry retail operations both domestically and globally.

Insider Ownership: 12.1%

Earnings Growth Forecast: 20.8% p.a.

MCLON JEWELLERY Ltd., while experiencing highly volatile share prices, has shown promising growth with a 42.1% earnings increase over the past year and an expected 20.8% annual growth rate, albeit slightly below the broader Chinese market's 22.1%. Its revenue growth at 23.4% annually surpasses the market average of 13.6%. However, shareholder dilution occurred last year and its dividend track record remains unstable despite recent dividend increases, reflecting a mixed financial discipline outlook.

SZSE:300945 Ownership Breakdown as at Jul 2024
SZSE:300945 Ownership Breakdown as at Jul 2024

Where To Now?

Want To Explore Some Alternatives?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com